K-Edge Spectral Imaging for Quantitative Cardiac Ablation Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cardiac catheter ablation procedures often fail due to inadequate assessment of tissue ablation, relying on qualitative visual observations of contrast agent presence or absence, which is insufficient for ensuring complete ablation.
Innovation Solution
An analyzer system that quantifies contrast material in scar tissue using contrast enhanced imaging data, compares the amount to predetermined thresholds, and generates recommendations for further ablation based on the analysis, utilizing a contrast agent with K-edge materials like bismuth, gold, or gadolinium to enhance imaging accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If qualitative visual observation of contrast agent is used to assess ablation, then the assessment process is simple and quick, but the measurement precision is insufficient to ensure complete ablation
Solution Approach 1:
The patent changes the parameter of contrast agent by using K-edge materials (gold, bismuth, gadolinium) with specific atomic numbers that absorb x-rays at particular energy thresholds. This allows the imaging system to detect ablated tissue through spectral analysis at specific energy levels, transforming a qualitative visual assessment into a quantitative measurement based on physical absorption parameters.
Solution Approach 2:
The patent adds a spectral dimension to the imaging system by using energy-resolving detectors that can distinguish x-ray photons at different energy levels. This transforms a single-dimensional visual observation into a multi-dimensional spectral analysis, enabling precise detection of contrast agent accumulation in ablated tissue through K-edge filtering.
2Measurement precision
If K-edge spectral imaging with energy-resolving detectors is used, then the measurement precision of contrast material quantification is improved, but the device complexity increases
Solution Approach 1:
The patent utilizes the K-edge absorption parameter of specific elements (gold at 80.7 keV, bismuth at 90.5 keV, gadolinium at 50.2 keV) to create energy-dependent contrast. By tuning the x-ray spectrum and using energy-resolving detectors, the system precisely measures contrast agent concentration based on these characteristic absorption edges, achieving high quantification accuracy.
Solution Approach 2:
The patent introduces K-edge filtering as an intermediary mechanism between the x-ray source and detector. The contrast agent containing K-edge materials acts as a spectral filter that selectively absorbs x-rays at specific energies, creating a measurable signal that mediates the interaction between the imaging system and the ablated tissue.
3Reliability
If quantitative assessment of contrast material is implemented, then the reliability of ablation completion determination is improved, but the difficulty of detecting and measuring increases
Solution Approach 1:
The patent implements a feedback mechanism where the quantified amount of contrast material in ablated tissue is compared against predetermined thresholds to generate actionable recommendations. The system continuously monitors contrast uptake and provides feedback on whether further ablation is needed, enabling iterative optimization of the ablation procedure based on real-time quantitative data.
Solution Approach 2:
The patent replaces manual visual assessment with an automated image processing and analysis system. The analyzer automatically quantifies contrast material distribution, compares measurements to thresholds, and generates recommendations, substituting the mechanical process of human visual inspection with an automated computational system that reduces measurement difficulty.
4Productivity
If contrast enhanced imaging with K-edge materials is used, then the productivity of ablation procedure optimization is improved, but the loss of time for imaging and analysis increases
Solution Approach 1:
The patent performs preliminary action by administering the contrast agent before or during the ablation procedure, allowing the imaging system to detect contrast accumulation in real-time or near-real-time. This enables the system to assess ablation effectiveness during the procedure itself rather than requiring separate post-procedure imaging sessions.
Solution Approach 2:
The patent maintains continuity of useful action by integrating the spectral imaging capability into the ablation procedure workflow. The energy-resolving detector continuously monitors contrast material distribution throughout the ablation process, allowing for uninterrupted assessment and immediate adjustment of ablation parameters without breaking the procedural flow.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides a quantitative assessment of ablation completeness, reducing the likelihood of unsuccessful procedures by determining if further ablation is needed, thereby improving the accuracy and effectiveness of cardiac catheter ablation.
Implementation Method 1
K-edge spectral imaging leverages the phenomena that high-Z elements tend to attenuate photons to a much higher extent above a particular energy (the K-edge energy of the given element) relative to attenuating photons just below the K-edge energy.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
An analyzer (124) includes a quantifier (204) configured to quantify an amount of contrast material representing scar tissue created by ablation for tissue of interest in contrast enhanced imaging data and a recommender (210) configured to generate a signal indicative of a recommendation to further ablate the tissue of interest in response to the quantified amount of the contrast material not satisfying a pre-determined threshold. A method includes obtaining contrast enhanced image data indicative of scar tissue created by ablation of tissue of interest, quantifying an amount of contrast material for the scar tissue in the tissue of interest, and generating a signal indicative of a recommendation to further ablate the tissue of interest in response to the quantified amount of the contrast material not satisfying a pre-determined threshold.